Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene

NCT00687102 is registered in ClinicalTrials.gov with Wake Forest University as lead sponsor.

NCT NCT00687102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00687102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Lead sponsor
Wake Forest University
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2001
Completion date
March 31, 2008
Enrollment
1,498 (actual)
Sites
134

Conditions

As the registry lists them; a condition with its own page is linked.

aging, cognition